Which has the lower trailing P/E, BIO or NRC?

BIO has the lower trailing P/E: BIO trades at 42.97 and NRC at 82.81. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIO or NRC?

Over the past five years, BIO grew revenue faster — BIO at a 0.29% CAGR versus NRC at -0.02%.

Does BIO or NRC pay a bigger dividend?

NRC pays a dividend (2.87% yield), while BIO has no payments in the available dividend history.

Is BIO or NRC more profitable?

BIO runs the higher net margin — BIO at 8.59% versus NRC at 4.18%.

How have BIO and NRC total returns compared?

Over the past 10 years, BIO delivered 8.69% and NRC delivered 4.74% annualized total return. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs NRC Health (NRC)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and NRC Health across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 11, 2026. Differences are shown without an overall score or investment verdict.

BIO

Bio-Rad Laboratories, Inc.

$9.59B

$356.25HealthcareDelayed quote: Aug 11, 2026, 4:00 PM EDT

NRC

NRC Health

$482M

$21.38HealthcareDelayed quote: Aug 11, 2026, 4:00 PM EDT

Total return — BIO vs NRC

growth of $100 · dividends reinvested · last 10y

BIO +127.4% (+8.6%/yr)NRC +60.6% (+4.9%/yr)BIO compounded faster over this window

BIO NRC

BIO vs NRC: by the numbers

•BIO is the larger company ($9.59B vs $482M market cap).
•BIO trades at the lower trailing earnings multiple (42.97 vs 82.81 P/E), one valuation lens rather than an overall verdict.
•BIO converts more revenue to profit (8.59% vs 4.18% net margin).
•BIO grew revenue faster over the past five years (0.29% vs -0.02% CAGR).
•NRC pays a dividend (2.87% yield), while BIO has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BIO	NRC
P/E ratio	42.97	82.81
Forward P/E	36.77	23.75
P/S ratio	3.67	3.29
P/B ratio	1.33	70.24
EV / EBITDA	26.74	23.40
FCF yield	3.71%	4.70%

Profitability

Metric	BIO	NRC
Gross margin	51.90%	56.33%
Operating margin	9.08%	10.53%
Net margin	8.59%	4.18%
ROE	3.10%	89.43%
ROIC	2.04%	14.36%

Dividends

Metric	BIO	NRC
Dividend yield	N/A	2.87%
Payout ratio	N/A	115.38%

Growth (annualized)

Metric	BIO	NRC
Revenue CAGR (5Y)	0.29%	-0.02%
EPS CAGR (5Y)	-26.27%	-18.88%
FCF CAGR (5Y)	-9.65%	-14.35%
Total return CAGR (5Y)	-14.23%	-15.40%

Frequently asked

Which has the lower trailing P/E, BIO or NRC?: BIO has the lower trailing P/E: BIO trades at 42.97 and NRC at 82.81. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIO or NRC?: Over the past five years, BIO grew revenue faster — BIO at a 0.29% CAGR versus NRC at -0.02%.
Does BIO or NRC pay a bigger dividend?: NRC pays a dividend (2.87% yield), while BIO has no payments in the available dividend history.
Is BIO or NRC more profitable?: BIO runs the higher net margin — BIO at 8.59% versus NRC at 4.18%.
How have BIO and NRC total returns compared?: Over the past 10 years, BIO delivered 8.69% and NRC delivered 4.74% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full NRC analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio NRC Health P/E ratio NRC Health dividend yield Bio-Rad Laboratories ROE NRC Health ROE Bio-Rad Laboratories operating margin NRC Health operating margin Bio-Rad Laboratories revenue growth NRC Health revenue growth Bio-Rad Laboratories free cash flow NRC Health free cash flow

Bio-Rad Laboratories & NRC Health appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 11, 2026.